Literature DB >> 31655988

Effect of Tripeptide Leu-Ile-Lys on the Course of Experimental Nephrolithiasis.

A Yu Zharikov1, N N Yakushev2, G V Zharikova2, O N Mazko2, O G Makarova2, A V Lepilov2, I P Bobrov2.   

Abstract

We studied the effect of Leu-Ile-Lys tripeptide on the course of experimental oxalate nephrolithiasis modeled in rats by administration of 1% ethylene glycol solution instead of drinking water for 6 weeks. The Leu-Ile-Lys tripeptide obtained by chemical synthesis (purity ≥98%) was administered through a gastric tube (11.5 mg/kg in 1 ml saline). Administration of Leu-Ile-Lys tripeptide against the background of experimental oxalate nephrolithiasis significantly alleviated the course of experimental pathology, which was confirmed by typical biochemical and morphological changes: decrease in urinary activity of γ-glutamyltransferase (by 2.1 times in comparison with the initial level) and intensity of oxidative stress (the content of TBA-reactive products decreased by 1.3 times in comparison with that in untreated animals) and increase in glutathione peroxidase activity by 1.8 times; no histological signs of nephrolithiasis were found in animals treated with the tripeptide.

Entities:  

Keywords:  Leu-Ile-Lys tripeptide; experimental urolithiasis; pharmacological activity

Mesh:

Substances:

Year:  2019        PMID: 31655988     DOI: 10.1007/s10517-019-04614-w

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

1.  Nephroprotective Effect of Leu-Ile-Lys Tripeptide in Experimental Diabetes Mellitus.

Authors:  G V Zharikova; A Yu Zharikov; O N Mazko; O G Makarova; I P Bobrov; A S Kalnitsky
Journal:  Bull Exp Biol Med       Date:  2022-06-23       Impact factor: 0.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.